Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Mulet

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Plos One|March 22, 2013
Creation of lung-targeted dexamethasone immunoliposome and its therapeutic effect on bleomycin-induced lung injury in ratsXue-Yuan Chen, Shan-Mei Wang, Nan Li, et al.
Drug Delivery|November 22, 2017
Surfactant protein-A nanobody-conjugated liposomes loaded with methylprednisolone increase lung-targeting specificity and therapeutic effect for acute lung injuryNan Li, Dong Weng, Shan-Mei Wang, et al.
International Journal of Nanomedicine|May 1, 2015
A novel nanobody specific for respiratory surfactant protein A has potential for lung targetingShan-Mei Wang, Xian He, Nan Li, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 25, 2018
Ceftolozane/tazobactam for the treatment of multidrug resistant Pseudomonas aeruginosa: experience from the Balearic IslandsManuel Díaz-Cañestro, Leonor Periañez, Xavier Mulet, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 24, 2026
Spin-Dependent Photoluminescence in Carbon-Based Quantum DotsErin S Grant, Joseph F Olorunyomi, Sam C Scholten, et al.
Biomaterials|January 3, 2012
Metal-free and MRI visible theranostic lyotropic liquid crystal nitroxide-based nanoparticlesBenjamin W Muir, Durga P Acharya, Danielle F Kennedy, et al.
Infection|May 4, 2024
Epidemiological and clinical characterization of community, healthcare-associated and nosocomial colonization and infection due to carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in SpainElena Salamanca-Rivera, Zaira R Palacios-Baena, Javier E Cañada, et al.
BMC Genomics|November 1, 2015
Genotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strainsJohn J Varga, Mariette Barbier, Xavier Mulet, et al.
Frontiers in Microbiology|February 14, 2022
Multicenter Performance Evaluation of MALDI-TOF MS for Rapid Detection of Carbapenemase Activity in Enterobacterales: The Future of Networking Data Analysis With Online SoftwareEva Gato, Ahalieyah Anantharajah, Manuel J Arroyo, et al.
Frontiers in Microbiology|July 18, 2022
CARB-ES-19 Multicenter Study of Carbapenemase-Producing <i>Klebsiella pneumonia</i>e and <i>Escherichia coli</i> From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3Javier E Cañada-García, Zaira Moure, Pedro J Sola-Campoy, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Plos One|March 22, 2013
Creation of lung-targeted dexamethasone immunoliposome and its therapeutic effect on bleomycin-induced lung injury in ratsXue-Yuan Chen, Shan-Mei Wang, Nan Li, et al.
Drug Delivery|November 22, 2017
Surfactant protein-A nanobody-conjugated liposomes loaded with methylprednisolone increase lung-targeting specificity and therapeutic effect for acute lung injuryNan Li, Dong Weng, Shan-Mei Wang, et al.
International Journal of Nanomedicine|May 1, 2015
A novel nanobody specific for respiratory surfactant protein A has potential for lung targetingShan-Mei Wang, Xian He, Nan Li, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 25, 2018
Ceftolozane/tazobactam for the treatment of multidrug resistant Pseudomonas aeruginosa: experience from the Balearic IslandsManuel Díaz-Cañestro, Leonor Periañez, Xavier Mulet, et al.
Advanced Materials (Deerfield Beach, Fla.)|February 24, 2026
Spin-Dependent Photoluminescence in Carbon-Based Quantum DotsErin S Grant, Joseph F Olorunyomi, Sam C Scholten, et al.
Biomaterials|January 3, 2012
Metal-free and MRI visible theranostic lyotropic liquid crystal nitroxide-based nanoparticlesBenjamin W Muir, Durga P Acharya, Danielle F Kennedy, et al.
Infection|May 4, 2024
Epidemiological and clinical characterization of community, healthcare-associated and nosocomial colonization and infection due to carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in SpainElena Salamanca-Rivera, Zaira R Palacios-Baena, Javier E Cañada, et al.
BMC Genomics|November 1, 2015
Genotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strainsJohn J Varga, Mariette Barbier, Xavier Mulet, et al.
Frontiers in Microbiology|February 14, 2022
Multicenter Performance Evaluation of MALDI-TOF MS for Rapid Detection of Carbapenemase Activity in Enterobacterales: The Future of Networking Data Analysis With Online SoftwareEva Gato, Ahalieyah Anantharajah, Manuel J Arroyo, et al.
Frontiers in Microbiology|July 18, 2022
CARB-ES-19 Multicenter Study of Carbapenemase-Producing <i>Klebsiella pneumonia</i>e and <i>Escherichia coli</i> From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3Javier E Cañada-García, Zaira Moure, Pedro J Sola-Campoy, et al.
Pageof 11